In summary, the regulation of biosynthesis and the processing of Let-7d using the ADAR1 isoforms should be the subject of new studies and, in the future, could be considered important therapeutic targets for idiopathic pulmonary fibrosis. This evidence concerns the gene ADAR and idiopathic pulmonary fibrosis.